Dear James,please be more specific. I do not know if you want to say how to put in the market a new vaccine? and desire to know what the different steps prior the commercialization? Am I right? If yes, tell me and I will type a full process.
Vaccines and some potential Antivirals are limited to specific mutations only. Many of the products on trial have unknown long term toxicities and will not be affordable to most Africans
Our Research is based on using low cost Pharmaceuticals to block entry of Ebola virons into Host cells which stops disease progression. This approach is not Mutation Specific.
Attached is a simple PROVIR antiviral formulation using readily available low cost Generic Pharmaceuticals.
As far as Ebola viral disease is concerned there is no safe commercial vaccine yet available in the market. Drugs however target the entry of Ebola virus in the host cell and block it so that there is no further progression of the disease.